Home/Carlsmed/Scott Durall

SD

Scott Durall

Chief Commercial Officer

Therapeutic Areas

Spine Surgery Neuroscience

Carlsmed Pipeline

Drug	Indication	Phase
aprevo® Personalized Interbody	Lumbar Interbody Fusion	Commercial
corra™ Personalized Cervical Plating System	Cervical Fixation/Stabilization	Early Commercialization
COMPASS™ Registry	Outcomes Data Collection (Spinal Fusion)	Registry

Leadership Team at Carlsmed

Mike Cordonnier

Chief Executive Officer & Chairman

Chief Financial Officer

Jennifer Kamocsay

Chief Legal Officer

Sharon Schulzki

Chief Clinical & Market Access Officer

Chief Technology Officer

View full Carlsmed profile